PADI3 Antibodies

Santa Cruz Biotechnology offers a broad range of PADI3 monoclonal antibodies for research focused on understanding peptidylarginine deiminase type 3. PADI3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PADI3, or peptidylarginine deiminase type 3, is an enzyme responsible for the post-translational modification of proteins through citrullination, which can affect protein function and interactions. PADI3 plays a significant role in skin biology and has been linked to various conditions, including autoimmune disorders and cancer. Research has shown that PADI3 activity influences multiple cellular pathways and biological processes. Understanding PADI3 function and regulation provides valuable insights into normal physiological processes and disease development. Investigating PADI3 expression patterns helps reveal its role in different tissue types and cellular environments. Exploring PADI3 interactions with other molecules advances knowledge of signaling networks and regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PADI3's role in health and disease.